Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Clinical trial NCT05375825 · WITHDRAWN

Trial details

NCT number: NCT05375825
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant Pleural Effusions, Malignant Mesothelin (Msln)

Start date: 2024-01-31
Primary completion: 2024-01-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.